New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Cancer patients may overly self-refer to emergency department

Cancer patients may overly self-refer to emergency department

by Lori SolomonAdults with cancer may not be using available clinician advice before self-referring to the emergency department, according to a study published online Sept. 14 in theAmerican Jou
World medicine December 01,2023
Cancer patients may overly self-refer to emergency department

Cancer patients may overly self-refer to emergency department

by Lori SolomonAdults with cancer may not be using available clinician advice before self-referring to the emergency department, according to a study published online Sept. 14 in theAmerican Jou
World medicine December 01,2023
CAR-like membrane protein determines all-trans retinoic acid response in colorectal cancer

CAR-like membrane protein determines all-trans retinoic acid response in colorectal cancer

by Li Yuan,Chinese Academy of SciencesCLMP regulates ATRA response via Wnt/β-catenin signaling in CRC. Credit: Bu Pengcheng's groupResearchers led by Prof. Bu Pengcheng from the Institute of
World medicine December 01,2023
CAR-like membrane protein determines all-trans retinoic acid response in colorectal cancer

CAR-like membrane protein determines all-trans retinoic acid response in colorectal cancer

by Li Yuan,Chinese Academy of SciencesCLMP regulates ATRA response via Wnt/β-catenin signaling in CRC. Credit: Bu Pengcheng's groupResearchers led by Prof. Bu Pengcheng from the Institute of
World medicine December 01,2023
Clinical trials present a new approach using immunotherapy combinations for bladder cancer treatment

Clinical trials present a new approach using immunotherapy combinations for bladder cancer treatment

byNetherlands Cancer InstituteCredit: Unsplash/CC0 Public DomainAfter 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approa
World medicine December 01,2023
Clinical trials present a new approach using immunotherapy combinations for bladder cancer treatment

Clinical trials present a new approach using immunotherapy combinations for bladder cancer treatment

byNetherlands Cancer InstituteCredit: Unsplash/CC0 Public DomainAfter 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approa
World medicine December 01,2023
Study: Prostate cancer focal therapy is cost-effective and may improve patient outcomes

Study: Prostate cancer focal therapy is cost-effective and may improve patient outcomes

by Ryan O'Hare,Imperial College LondonCredit: Los Muertos Crew from PexelsMinimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality
World medicine December 01,2023
Study: Prostate cancer focal therapy is cost-effective and may improve patient outcomes

Study: Prostate cancer focal therapy is cost-effective and may improve patient outcomes

by Ryan O'Hare,Imperial College LondonCredit: Los Muertos Crew from PexelsMinimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality
World medicine December 01,2023
DNA tangles allow for targeted cancer therapy via topoisomerase drug treatment

DNA tangles allow for targeted cancer therapy via topoisomerase drug treatment

byKarolinska InstitutetScheme describing TOP1 regulation during pause release. BRD4 and TOP1 activities are required to overcome promoter-proximal pausing and enable efficient transcription elon
World medicine December 01,2023
DNA tangles allow for targeted cancer therapy via topoisomerase drug treatment

DNA tangles allow for targeted cancer therapy via topoisomerase drug treatment

byKarolinska InstitutetScheme describing TOP1 regulation during pause release. BRD4 and TOP1 activities are required to overcome promoter-proximal pausing and enable efficient transcription elon
World medicine December 01,2023
Study suggests dental professionals can play a crucial role in identifying signs of chronic disease

Study suggests dental professionals can play a crucial role in identifying signs of chronic disease

by Alan Williams,University of PlymouthCredit: Anna Shvets from PexelsDental professionals can make a marked and positive difference to public health by being trained to spot some of the key mar
World medicine December 01,2023
Study suggests dental professionals can play a crucial role in identifying signs of chronic disease

Study suggests dental professionals can play a crucial role in identifying signs of chronic disease

by Alan Williams,University of PlymouthCredit: Anna Shvets from PexelsDental professionals can make a marked and positive difference to public health by being trained to spot some of the key mar
World medicine December 01,2023
Two-drug approach could overcome a common cancer mutation, make treatments more effective

Two-drug approach could overcome a common cancer mutation, make treatments more effective

by Stephanie Dutchen,Harvard Medical SchoolCredit:Cell(2023). DOI: 10.1016/j.cell.2023.10.006Cancer cells are often a mess of mutations. About 20% to 25% of cancers involve mutations
World medicine December 01,2023
Two-drug approach could overcome a common cancer mutation, make treatments more effective

Two-drug approach could overcome a common cancer mutation, make treatments more effective

by Stephanie Dutchen,Harvard Medical SchoolCredit:Cell(2023). DOI: 10.1016/j.cell.2023.10.006Cancer cells are often a mess of mutations. About 20% to 25% of cancers involve mutations
World medicine December 01,2023
Spanish-speaking men in sexual minority groups may lack knowledge about cancers linked to HPV

Spanish-speaking men in sexual minority groups may lack knowledge about cancers linked to HPV

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA study found multiple gaps in awareness and knowledge about the connection between the human papillomavirus (HPV) and
World medicine December 01,2023
Spanish-speaking men in sexual minority groups may lack knowledge about cancers linked to HPV

Spanish-speaking men in sexual minority groups may lack knowledge about cancers linked to HPV

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA study found multiple gaps in awareness and knowledge about the connection between the human papillomavirus (HPV) and
World medicine December 01,2023
Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

byAmerican Roentgen Ray SocietyLesion (arrow) shows hypointensity on T2-weighted image (A), hyperintensity on high b-value DWI (B), hypointensity on ADC map (C), and focal early enhancement on d
World medicine December 01,2023
Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

byAmerican Roentgen Ray SocietyLesion (arrow) shows hypointensity on T2-weighted image (A), hyperintensity on high b-value DWI (B), hypointensity on ADC map (C), and focal early enhancement on d
World medicine December 01,2023
Better cancer diagnosis thanks to digital 3D images

Better cancer diagnosis thanks to digital 3D images

by Deborah Kyburz,ETH ZurichFrancesca Catto and Robert Axelrod are looking forward to the launch of their start-up and the roll-out of the product. Credit: ETH Zurich / Daniel WinklerIt all star
World medicine December 01,2023
Better cancer diagnosis thanks to digital 3D images

Better cancer diagnosis thanks to digital 3D images

by Deborah Kyburz,ETH ZurichFrancesca Catto and Robert Axelrod are looking forward to the launch of their start-up and the roll-out of the product. Credit: ETH Zurich / Daniel WinklerIt all star
World medicine December 01,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com